Novo Nordisk · 1 day ago
Internship - GLP-1 Diabetes Consumer Marketing
Novo Nordisk is a global pharmaceutical company focused on creating human-centered experiences in healthcare. The internship position involves executing digital consumer marketing strategies, conducting research to enhance patient support materials, and supporting the brand team with various marketing tasks.
BiotechnologyHealth CareMedicalPharmaceutical
Responsibilities
Ensure the successful execution of digital consumer marketing strategy with a focus on Website, CRM, and Paid Social channel optimization
Conduct research to evaluate current digital patient support offerings and develop recommendations on how to enhance support materials to drive patient engagement and positive experiences with the GLP-1 Diabetes brand
Assist in review of creative materials including website, email, SMS, and social media content, prior to PRB (Promotional Review Board) submission to ensure consistency with strategy and pharma guidelines
Support the brand team with ad hoc requests such as participating in workshops, brainstorming sessions, agency coordination, etc
Qualification
Required
Must be a current student enrolled or recently graduated (graduation date no earlier than April 2026) at/from an accredited college or university pursuing at least a bachelor's degree
Strong academic record with a preferred cumulative GPA of 3.0 or higher
Conscientious self-starter with good organizational skills, project management skills and attention to detail
Ability to balance multiple projects and priorities, must be able to multi-task
Strong interpersonal communication and ability to collaborate with teams; must effectively operate independently, across functional lines, and with internal customers
Demonstrated personal initiative, self-motivation, flexibility, adaptability and willingness to learn
Proficient in Microsoft Office Tools including Word, Excel, PowerPoint, etc
Preferred
A completed or in progress undergraduate degree in Business Administration, Marketing or a related discipline preferred
Company
Novo Nordisk
Novo Nordisk is a healthcare company that produces and distributes insulin and other diabetes drugs to treat chronic diseases.
Funding
Current Stage
Public CompanyTotal Funding
$22M2018-12-05Post Ipo Equity· $22M
1981-07-09IPO
Recent News
Labiotech UG
2026-01-24
bloomberglaw.com
2026-01-24
Company data provided by crunchbase